BioSyent sees 14% rise in Q3 sales
The sales in the first nine months of 2010 were $1,216,019 compared to $911,543 in the corresponding previous year period. BioSyent incurred a loss of $31,987 in the
Made Scientific has acquired an 85,000ft² cell therapy manufacturing facility in Pennsylvania, US, from National Resilience, adding an operational site to its US East Coast network.